AI Verdict
IMCR has stronger fundamentals based on our AI analysis.
IMCR vs IMA Fundamental Comparison
| Metric | IMCR | IMA |
|---|---|---|
| Revenue | $400.0M | $800,000.0 |
| Net Income | $-35.5M | $-45.3M |
| Net Margin | -8.9% | -5,668.6% |
| ROE | -9.3% | -34.1% |
| ROA | -3.3% | -29.6% |
| Current Ratio | 4.04x | 12.49x |
| Debt/Equity | 1.15x | 0.00x |
| EPS | $-0.71 | $-9.64 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMCR vs IMA: Frequently Asked Questions
Is IMCR or IMA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMCR has stronger fundamentals. IMCR is rated HOLD (65% confidence) while IMA is rated STRONG SELL (85% confidence). This is not investment advice.
How does IMCR compare to IMA fundamentally?
Immunocore Holdings plc has ROE of -9.3% vs ImageneBio, Inc.'s -34.1%. Net margins are -8.9% vs -5,668.6% respectively.
Which stock pays higher dividends, IMCR or IMA?
IMCR has a dividend yield of N/A or no dividend while IMA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMCR or IMA for long term?
For long-term investing, consider that IMCR has HOLD rating with 65% confidence, while IMA has STRONG SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMCR vs IMA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMCR vs IMA, the AI consensus favors IMCR based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.